Does A Broad Spectrum CBG Provide Health Benefits?

Does A Broad Spectrum CBG Provide Health Benefit? This article will examine the benefits of Cannabigerol and whether it has potential as a neuroprotectant, skin barrier improver, and treatment for glaucoma. Read on for more information. This ephemeral phytocannabinoid has also been shown to have the potential to treat glaucoma.

Cannabigerol

Cannabigerol, a compound in cannabis, has similar therapeutic effects to cannabidiol, the active ingredient in marijuana. Yet, there is still little research on cannabigerol. While it is a relatively unregulated molecule, further study of its benefits for human health is needed. Cannabigerol is a promising candidate for future research if used as a dietary supplement.

Cannabigerol is made by marijuana plants and is found in trace amounts in many strains. It is a minor cannabinoid that does not produce the psychoactive effect that CBD does. As such, it may help mitigate the adverse effects of THC. Although it does not have a high, cannabigerol is a promising option for various health conditions.

The plant contains over 100 phytocannabinoids, but cannabigerol is the one that has the most widespread and beneficial effects. This is because Cannabigerol acts on the body’s endocannabinoid system, making it an excellent therapeutic candidate. While THC and CBD are more commonly found in the cannabis plant, cannabigerol is a precursor to both.

Cannabigerol as a neuroprotectant

There are several promising applications for cannabigerol. In an animal study, CBG decreased eye pressure and increased aqueous humor outflow, two important mechanisms that maintain eye pressure and provide nutrition. Further, the cannabinoid was influential in treating Huntington’s disease, an inherited disorder in which nerve cells in the brain die off. Using cannabigerol decreased these animals’ motor deficits and protected neurons from the toxicity of 3-nitropropionic acid.

Cannabigerol is a precursor molecule to the most abundant phytocannabinoids, including THC. Cannabigerol has unique interactions with cannabinoid receptors, including the a2 adrenoceptor and 5-hydroxytryptamine (5-HT1A) receptors. Because of its interactions with these receptors, cannabigerol could be used to treat several neurologic conditions.

Cannabigerol as a skin barrier improver

Cannabigerol, a nonpsychoactive minor cannabinoid found in low concentrations in Cannabis sativa L., serves as a direct precursor to cannabidiol and tetrahydrocannabinol, two other significant cannabinoids. Although cannabidiol (CBD) and tetrahydrocannabinol (THC) have extensive research on their beneficial skin effects, there is little information on CBG.

Cannabigerol as a possible treatment for glaucoma

The use of cannabis in medicine is gaining popularity as a possible treatment for glaucoma. Glaucoma is a degenerative eye disease characterized by increased pressure within the eye. This pressure causes damage to the optic nerve, the part of the eye that sends images to the brain. It is the second leading cause of blindness in the United States. Some people are genetically predisposed to glaucoma, and those with thinner corneas and chronic eye inflammation are at an increased risk of developing the disease. Certain medications may also increase the risk of glaucoma.

There is no proven medical benefit of marijuana for glaucoma, but it is a valid medical indication in many states. Cannabinoids have neuroprotective properties, making them helpful in treating optic nerve damage. They also have the potential to reduce intraoral and intravenous IOP. And because cannabinoids have anti-angiogenic properties, they can be used as a treatment for conjunctivitis and ophthalmitis.